SB

Stephane Birkle

UN Universite De Nantes: 4 patents #16 of 365Top 5%
OP Ogd2 Pharma: 3 patents #4 of 8Top 50%
CN CNRS: 1 patents #3,857 of 11,908Top 35%
IL Institut De Cancerologie De L'Ouest: 1 patents #6 of 15Top 40%
NU Nantes Universite: 1 patents #9 of 41Top 25%
Overall (All Time): #945,537 of 4,157,543Top 25%
5
Patents All Time

Issued Patents All Time

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
11697689 Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic potential of drugs Julien FLEURENCE, Sébastien FARAJ, Jean-Marc Le Doussal, Denis Cochonneau, Mickaël TERME +1 more 2023-07-11
10745489 Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strategy for Cancer Stem Cells cancer Denis Cochonneau, Mylene Dorvillius, Jean-Marc Le Doussal, Mickaël TERME 2020-08-18
10000575 Targeting O-acetylated GD2 ganglioside as a new therapeutic and diagnostic strategy for cancer stem cells cancer Denis Cochonneau, Mylene Dorvillius, Jean-Marc Le Doussal, Mickaël TERME 2018-06-19
9334330 Use of monoclonal antibodies specific to the O-acetylated form of GD2 ganglioside for the treatment of certain cancers Jean-Marie Mussini, Jacques A. Aubry, Jacques Barbet, Jean-Francois Chatal, Beatrice Clemenceau 2016-05-10
8951524 Use of monoclonal antibodies specific to the O-acetylated form of GD2 ganglioside for treatment of certain cancers Jean-Marie Mussini, Jacques A. Aubry, Jacques Barbet, Jean-Francois Chatal 2015-02-10